Sao Paulo may use Sinovac vaccine without Brazil regulator's approval, governor says - (NASDAQ via NewsPoints Desk)

  • The Brazilian state of Sao Paulo could roll out Sinovac's CoronaVac vaccine against SARS-CoV-2 even without approval from the federal health regulator Anvisa, as reported in NASDAQ.

  • The state's governor Joao Doria made the suggestion amid concern among some critics of President Jair Bolsonaro that the independence of Anvisa is under threat.

  • Doria said Sao Paulo could use the Sinovac vaccine based on approval from health regulators in other countries, adding "there is suspicion that Anvisa could suffer political interference."

  • He added the state would consider the vaccine appropriate for use if approved by authorities "in the US, in Europe and, above all, in Asia."

  • According to the news source, the Brazilian government's principal bet has been on a COVID-19 vaccine being developed by AstraZeneca, though federal health officials have also held talks with other vaccine developers, such as Johnson & Johnson and Pfizer.

To read more NewsPoints articles, click here.